Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia

Efficacy and safety of treatment with Incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity

(2011) P Kaňovský et al.   JOURNAL OF REHABILITATION MEDICINE

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia

(2011) Cynthia L. Comella et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Noninferiority of IncobotulinumtoxinA, Free from Complexing Proteins, Compared with Another Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines

(2010) GERHARD SATTLER et al.   DERMATOLOGIC SURGERY

Botulinum toxin for treatment of dystonia

(2010) D. Dressler   EUROPEAN JOURNAL OF NEUROLOGY

EFNS guidelines on diagnosis and treatment of primary dystonias

(2010) A. Albanese et al.   EUROPEAN JOURNAL OF NEUROLOGY

RimabotulinumtoxinB Effects on Pain Associated with Cervical Dystonia: Results of Placebo and Comparator-Controlled Studies

(2010) Mark F. Lew et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm

(2010) Bettina Wabbels et al.   JOURNAL OF NEURAL TRANSMISSION

A long-term follow-up of botulinum toxin A in cervical dystonia

(2009) B. Mohammadi et al.   NEUROLOGICAL RESEARCH

Xeomin is free from complexing proteins

(2009) Jürgen Frevert   TOXICON

Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay

(2008) Mitchell F. Brin et al.   MOVEMENT DISORDERS

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review)

(2008) D. M. Simpson et al.   NEUROLOGY